Ivermectin Tablets IP 12 mg Manufacturer

Ivermectin Tablets IP 12 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Ivermectin Tablets IP 12 mg Manufacturer product packaging

Ivermectin Tablets IP 12 mg | Manufacturer

Product image for Ivermectin Tablets IP 12 mg Manufacturer; contract manufacturing, oem & quality control.

Product Information

Generic NameIvermectin
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049021
PharmacopoeiaIP
Product TypeTablet
CategoryAnthelmintic drugs
SubcategoryAnthelmintic drugs
Active IngredientIvermectin
Strength12 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAnthelmintic drugs

Medicine Details & Safety

Short DescriptionHealthy Life Pharma invites contract and third-party manufacturing enquiries for Ivermectin Tablets IP 12 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.
Approved Uses / Indications1. Treatment of upper and lower respiratory tract infections (bronchitis, pneumonia, sinusitis, pharyngitis). 2. Treatment of skin and soft tissue infections, uncomplicated urinary tract infections, and gastrointestinal bacterial infections.
Full Description

Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ivermectin Tablets IP 12 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements.

Product technical specifications

Generic nameIvermectin
CompositionIvermectin
Strength12 mg
CategoryAnthelmintic drugs
PharmacopoeiaIP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Manufacturing capabilities and infrastructure

For Ivermectin Tablets IP 12 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.

Quality control and assurance

Request the approved finished-product specification for Ivermectin Tablets IP 12 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.

Primary and secondary packaging

The catalogue pack for Ivermectin Tablets IP 12 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.

Contract manufacturing and private label

Submit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution.
Dosage InstructionsAdminister orally at evenly spaced intervals around the clock. Swallow whole with water; complete the entire prescribed antimicrobial regimen even if symptoms resolve earlier, to prevent emergence of antimicrobial resistance.
Side EffectsCommon: Nausea, diarrhea, abdominal cramps, vomiting, dysgeusia (taste alteration). Uncommon: Headache, dizziness, candidiasis (oral or vaginal thrush), transient transaminase rise. Rare: Pseudomembranous colitis (C. difficile), severe cutaneous adverse reactions, anaphylaxis.
Warnings and PrecautionsAntimicrobial Resistance: Use strictly for culture-proven or strongly suspected bacterial infections. Clostridioides difficile Colitis: Discontinue immediately if severe, persistent watery diarrhea develops. Hypersensitivity Alert: Screen for past history of drug allergies before initiation.
Contraindications1. Documented hypersensitivity to Ivermectin or chemically related antibacterial classes.
2. Severe hepatic necrosis or jaundice associated with prior use.
3. Concurrent use with contraindicated QTc-prolonging or hepatotoxic substances.
Drug Interactions1. Antacids & Polyvalent Cations (Al, Mg, Fe, Ca): Significantly reduce oral bioavailability; separate dosing by 2 hours.
2. Oral Anticoagulants (Warfarin): May potentiate hypoprothrombinemic effect and elevate INR.
3. Live Vaccines: Antibacterial therapy may attenuate response to oral typhoid or BCG vaccine.

Frequently Asked Questions

QuestionAnswer
Can I request third-party manufacturing for Ivermectin Tablets IP 12 mg?Submit your brand, quantity and packaging requirements for manufacturing feasibility review.
Which pharmacopoeial standard applies for Ivermectin Tablets IP 12 mg?The source specification is IP; confirm the required standard before contracting.
What quality tests are applicable for Ivermectin Tablets IP 12 mg?Request the approved finished-product specification and batch testing plan.
Can packaging be customized for Ivermectin Tablets IP 12 mg?Submit artwork and pack requirements for technical and regulatory review.
How do I request a manufacturing quotation for Ivermectin Tablets IP 12 mg?Provide forecast volume, target market, strength and packaging requirements.

Product Hashtags

#Ivermectin#Manufacturer#PharmaB2B

Related Products

Latest Posts